| Catalog Number |
ACMA00065395 |
| Description |
Lenvatinib is intended for Pharmaceuticals applications. Lenvatinib is a multiple receptor tyrosine kinase inhibitor (TKI) used to treat certain type of thyroid cancer, kidney cancer and liver cancer. All information about [2H5]-Lenvatinib is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents |
| Synonyms |
E7080-d5, 4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide-d5 |
| Molecular Weight |
431.89 |
| Molecular Formula |
C21H19ClN4O4 |
| Purity |
≥98% |
| Isotopic Enrichment |
98% 2H |
| Stability |
≥1 year |
| Unlabeled CAS |
417716-92-8 |
Please kindly note that our products and services are for research use only.
